DaVita Inc.: financial analysis
Ratios worked out from 10 fiscal years of DaVita Inc.'s statements, compared with 48 companies in Medical Care Facilities.
DaVita Inc. scorecard#
Passes 17 of the 24 checks that could be worked out: strongest in profitability (4 of 4), weakest in growth (3 of 6). Fiscal year 2025; market cap of Oct 28, 2026.
Valuation5 of 6
- ✓P/E below its peers' median12.4×P/E 12.4× against Medical Care Facilities's median of 27.4×.
- ✗Price to book below its peers' medianNo price to bookShareholders' equity is negative.
- ✓Price to sales below its peers' median0.8×Price to sales 0.8× against Medical Care Facilities's median of 1.4×.
- ✓Free cash flow yield above 5%11.5%Free cash flow is 11.5% of the market value.
- ✓Earnings yield above the 10-year Treasury yield8.1%Earnings yield 8.1% against the 10-year Treasury's 4.92% on 2026-11-20.
- ✓The price assumes slower growth than the last three years'-5.1%The price assumes -5.1% a year for ten years; revenue grew 5.5% a year over the last three.
Growth3 of 6
- ✓Revenue grew in the newest year6.5%Revenue up 6.5% in fiscal 2025.
- ✓Revenue up more than 5% a year over three years5.5%5.5% a year over the three years to fiscal 2025.
- ✗Faster growth over three years than its peers' median5.5%5.5% a year against Medical Care Facilities's median of 9.0% (33 companies).
- ✗Earnings per share grew in the newest year9.84 vs 10.73Diluted EPS 9.84 in fiscal 2025 against 10.73 the year before (report's currency).
- ✗Net income higher than five years earlier$747 M$747 M in fiscal 2025 against $774 M in 2020.
- ✓Revenue rose in at least four of the last five years4 of 5Revenue rose in 4 of the five years to fiscal 2025.
Profitability4 of 4
- ✓Profitable in the newest year$747 MNet income $747 M in fiscal 2025.
- ✓Profitable in each of the last five years5 of 5Profitable in 5 of the five years to fiscal 2025.
- ✓Operating margin above its peers' median15.0%15.0% against Medical Care Facilities's median of 7.8% (37 companies).
- –Return on equity above 15%No return on equity (equity missing or negative).
- –Return on invested capital above 10%No return on invested capital on file.
- ✓Operating margin wider than three years earlier15.0%15.0% in fiscal 2025 against 11.5% in 2022.
Financial health2 of 4
- ✓Short-term assets cover short-term liabilities1.3×Current ratio 1.29 at the end of fiscal 2025.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- ✗Operating income covers interest five times3.8×Operating income 3.8 times interest in fiscal 2025.
- ✓Cash from operations positive in each of the last three years3 of 3Positive in 3 of the three years to fiscal 2025.
- ✗Altman Z-score outside the distress zone1.62Z-score 1.62 (distress zone) for fiscal 2025.
Shareholder returns3 of 4
- ✗Pays a dividendNoNo dividends in fiscal 2025.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✓Share count up no more than 2% in a year-13.1%Diluted shares down 13.1% in fiscal 2025.
- ✓Dividends and buybacks above 3% of the market value11.4%Dividends and buybacks were 11.4% of the market value.
- ✓Free cash flow covers dividends and buybacks$1.3 BFree cash flow $1.3 B against $1.3 B paid out in fiscal 2025.
Worked out from the statements as filed (sec), the medians of Medical Care Facilities, the 10-year Treasury yield of Nov 20, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
What the 2025 statements show#
Each line is an observation with its numbers, not a judgement of the company.
Strengths
- Revenue has grown 3 years in a row.
- Free cash flow has been positive 17 years in a row.
- The share count fell 13.1% in the year (buybacks).
Worth a look
- Shareholders' equity is negative: -$651 million.
Piotroski F-score
Nine yes/no tests of whether the company's finances improved in the year. One point each.
- Made a profityes
- Operations brought in cashyes
- Return on assets roseno
- Cash from operations exceeds profityes
- Long-term debt fell against assetsno
- Current ratio roseyes
- No new shares issuedyes
- Gross margin rosenot on file
- Asset turnover roseyes
Altman Z-score
A 1968 formula that weighs five balance-sheet ratios. It was built on listed manufacturers and says less about other kinds of company.
| Part | Ratio | Weight | Points |
|---|---|---|---|
| Working capital to assets | 0.05 | × 1.2 | 0.06 |
| Retained earnings to assets | -0.02 | × 1.4 | -0.03 |
| Operating income to assets | 0.12 | × 3.3 | 0.39 |
| Market value to liabilities | 0.70 | × 0.6 | 0.42 |
| Revenue to assets | 0.78 | × 1 | 0.78 |
Profitability#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Operating margin | 15.0% | 16.3% | 13.2% | 11.5% | 15.5% | 7.8% | 97% | |
| Net margin | 5.5% | 7.3% | 5.7% | 4.8% | 8.4% | 3.1% | 71% | |
| Return on equity | — | 159.1% | 78.2% | 76.4% | 91.5% | 7.8% | — | |
| Return on assets | 4.3% | 5.5% | 4.1% | 3.3% | 5.7% | 2.1% | 70% | |
| Return on invested capital | — | — | — | — | — | 10.9% | — |
Growth#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Revenue growth | 6.5% | 5.6% | 4.6% | -0.1% | 0.6% | 6.7% | 48% | |
| Revenue growth, 3 years a year | 5.5% | 3.3% | 1.7% | 0.6% | 0.6% | 9.0% | 34% | |
| Revenue growth, 5 years a year | 3.4% | 2.4% | 1.3% | 1.3% | 1.7% | 8.3% | 34% | |
| Net income growth | -20.2% | 35.4% | 23.4% | -42.7% | 26.5% | 17.8% | 18% | |
| Earnings per share growth | -8.3% | 44.6% | 26.8% | -34.3% | 41.1% | 17.5% | 27% |
Financial strength#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Debt to equity | — | — | — | — | — | 0.56× | — | |
| Net debt | — | — | — | — | — | $406 M | — | |
| Net debt to EBITDA | — | — | — | — | — | 2.61× | — | |
| Interest cover | 3.79× | 4.80× | 4.29× | 3.95× | 6.73× | 1.08× | 75% | |
| Current ratio | 1.29× | 1.26× | 1.19× | 1.20× | 1.32× | 1.31× | 49% | |
| Equity share of assets | -3.7% | 0.7% | 6.3% | 4.2% | 4.4% | 29.5% | 15% |
Cash#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Free cash flow | $1.3 B | $1.5 B | $1.5 B | $961 M | $1.3 B | $107 M | 94% | |
| Free cash flow margin | 9.6% | 11.4% | 12.3% | 8.3% | 11.1% | 5.1% | 75% | |
| Cash conversion | 252.6% | 216.0% | 297.8% | 279.2% | 197.3% | 195.3% | 70% | |
| Capital spending share of revenue | 4.2% | 4.3% | 4.7% | 5.2% | 5.5% | 2.5% | — |
Efficiency#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Asset turnover | 0.78× | 0.75× | 0.72× | 0.68× | 0.68× | 0.78× | 50% |
How each figure is worked out#
- Operating margin
- Operating income as a share of revenue.
- Net margin
- Net income as a share of revenue.
- Return on equity
- Net income as a share of shareholders' equity (the average of the start and the end of the year). Not given when equity is negative.
- Return on assets
- Net income as a share of total assets (average of the year).
- Return on invested capital
- Operating income after tax, as a share of debt plus equity less cash (average of the year). The tax rate is the year's own: income tax over pre-tax income.
- Revenue growth
- Revenue against the year before.
- Revenue growth, 3 years a year
- The yearly rate that takes revenue of three years earlier to this year's.
- Revenue growth, 5 years a year
- The yearly rate that takes revenue of five years earlier to this year's.
- Net income growth
- Net income against the year before. Only when both years were profitable.
- Earnings per share growth
- Diluted earnings per share against the year before. Only when both were positive.
- Debt to equity
- Total debt divided by shareholders' equity. Not given when equity is negative.
- Net debt
- Total debt less cash. Negative means more cash than debt.
- Net debt to EBITDA
- Debt less cash, divided by operating income plus depreciation and amortization: roughly the years of operating earnings needed to repay it.
- Interest cover
- Operating income divided by the interest paid on debt.
- Current ratio
- Assets due within a year divided by liabilities due within a year.
- Equity share of assets
- Shareholders' equity as a share of total assets.
- Free cash flow
- Cash from operations less capital spending.
- Free cash flow margin
- Free cash flow as a share of revenue.
- Cash conversion
- Cash from operations as a share of net income. Only when the year was profitable.
- Capital spending share of revenue
- Capital spending as a share of revenue.
- Dividend yield
- Dividends paid in the fiscal year as a share of today's market value.
- Buyback yield
- Shares bought back in the fiscal year as a share of today's market value.
- Shareholder yield
- Dividends plus buybacks as a share of today's market value.
- Dividend payout
- Dividends paid as a share of net income. Only when the year was profitable.
- Change in share count
- Diluted shares against the year before. Negative: fewer shares.
- Asset turnover
- Revenue divided by total assets (average of the year).